Bit Capital Gmb H Magenta Therapeutics, Inc. Transaction History

Bit Capital Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 12, 2025	SELL	$0.36 - $1.59 $61,822 - $273,049	-171,729 Closed	0 $0
Q3 2022 Feb 12, 2025	BUY	$1.26 - $2.09 $119,988 - $199,028	95,229 Added 124.48%	171,729 $230 Million
Q2 2022 Feb 12, 2025	BUY	$0.97 - $3.08 $33,950 - $107,800	35,000 Added 84.34%	76,500 $95.6 Million
Q1 2022 Feb 12, 2025	BUY	$2.55 - $5.23 $105,824 - $217,045	41,500 New	41,500 $140 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.